Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897103 · ClinicalTrials.gov registry record
Platelet Activity in Vascular Surgery for Thrombosis and Bleeding
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 200
- Enrollment target
NCT01897103 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 200 participants.
The verdict
NCT01897103 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers during the perioperative period. The goal is to develop a clinically useful assessment of platelet/coagulation activity for risk stratification that may ultimately serve as a target for therapeutic intervention. This study will enroll 200 patients with peripheral artery disease undergoing vascular surgery. PIVOTAL is funded by American Heart Association and is scheduled to begin enrollment in July 2013 for approximately two years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01897103
The ClinicalTrials.gov registry entry for NCT01897103 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01897103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01897103 about?
NCT01897103 is a clinical study titled "Platelet Activity in Vascular Surgery for Thrombosis and Bleeding". The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers during the perioperative period. The goal is to develop a clinically useful assessment of platelet/coagulation activity for risk stratification that may ultimately serve as a target for therapeutic intervention....
What is the current status of trial NCT01897103?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2013-06. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT01897103?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.